LucioNavarroGordanMD(He/Him)
Oncology • Gainesville, FLHematologic Oncology
MD Managing Physician and President of Florida Cancer Specialists; Exec Board COA; Exec Board of Flasco
Dr. Gordan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Florida Cancer Specialists (GCC)
6420 W Newberry Rd, East Wing, Suite 100
Gainesville, FL 32605Phone+1 352-332-3900Fax+1 352-332-5009
Summary
- Dr. Lucio Gordan is an oncologist in Gainesville, FL and is affiliated with North Florida Regional Medical Center. He received his medical degree from Other and has been in practice 24 years. He specializes in hematologic oncology and is experienced in hematologic oncology and general / benign hematology.
Education & Training
University of FloridaFellowship, Hematology and Medical Oncology, 2000
University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 1994 - 1997
OtherClass of 1994
Certifications & Licensure
UT State Medical License 2018 - 2026
TX State Medical License 2019 - 2026
IL State Medical License 2018 - 2026
FL State Medical License 1997 - 2025
AZ State Medical License 2018 - 2023
OH State Medical License 2018 - 2023
NC State Medical License 2018 - 2023- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2011-2014
Clinical Trials
- Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy Start of enrollment: 2006 Feb 01
- Study of Talabostat + Docetaxel Versus Docetaxel in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy Start of enrollment: 2006 Jan 01
Publications & Presentations
PubMed
- 7 citationsImmune checkpoint inhibitor associated renally limited thrombotic microangiopathy - a clinical dilemma.Sherif Badra, Rupam Ruchi, Xu Zeng, Lucio Gordan, Chintan V Shah
European Journal of Cancer. 2022-07-01 - 98 citationsPhase II Trial of Individualized Rituximab Dosing for Patients With CD20-Positive Lymphoproliferative DisordersLucio N. Gordan, William B. Grow, Annette Pusateri, Vonda Douglas, Nancy P. Mendenhall
Journal of Clinical Oncology. 2005-02-20 - 12 citationsCompromised Outcomes in Stage IV Non-Small-Cell Lung Cancer With Actionable Mutations Initially Treated Without Tyrosine Kinase Inhibitors: A Retrospective Analysis of...Jeffrey A Scott, Jochen Lennerz, Melissa Lynne Johnson, Lucio N Gordan, Robert H Dumanois
JCO Oncology Practice. 2024-01-01
Press Mentions
Florida Cancer Specialists & Research Institute Physicians Advancing Breakthroughs in Cancer ImmunotherapyNovember 7th, 2024- Florida Cancer Specialists & Research Institute Real-World Evidence Capabilities Contributing to Breakthroughs in Blood Cancer Treatment WorldwideSeptember 24th, 2024
- Florida Cancer Specialists & Research Institute Contributing to Transformative Cancer Therapies WorldwideSeptember 12th, 2024
- Join now to see all
Professional Memberships
- Member
Other Languages
- Portuguese, Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
